412 results on '"Shimabukuro-Vornhagen, Alexander"'
Search Results
2. Übergaben auf der Intensivstation
3. Teamspezifische Auswirkungen der Corona-Pandemie auf Mitarbeiter:innen der Internistischen Intensivmedizin eines Krankenhauses der Maximalversorgung
4. Characteristics and outcomes of patients undergoing high-dose chemotherapy and autologous stem cell transplantation admitted to the intensive care unit: a single-center retrospective analysis
5. Hyperleukocytosis in patients with acute myeloid leukemia admitted to the intensive care unit: a single-center retrospective analysis
6. Veno-venous extracorporeal membrane oxygenation (vv-ECMO) for severe respiratory failure in adult cancer patients: a retrospective multicenter analysis
7. Allogeneic stem cell transplant recipients admitted to the intensive care unit during the peri-transplant period have unfavorable outcomes—results of a retrospective analysis from a German university hospital
8. Handoffs in the intensive care unit
9. Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
10. Intensive Care Unit Organization and Interdisciplinary Care for Critically Ill Patients with Cancer
11. Kreislauftherapie bei Sepsis – wann, wie und wie viel?
12. A diagnostic challenge—First case of chronic lymphatic leukemia‐associated necrotizing sweet syndrome.
13. Evaluation of intubation and intensive care use of the new Ambu® aScope™ 4 broncho and Ambu® aView™ compared to a customary flexible endoscope a multicentre prospective, non-interventional study
14. Airway Pressure Release Ventilation in COVID-19-Associated Acute Respiratory Distress Syndrome—A Multicenter Propensity Score–Matched Analysis.
15. ‘Lost in Nasal Space’: Staphylococcus aureus sepsis associated with Nasal Handkerchief Packing
16. Unerwartete Toxizitäten neuer Substanzen
17. Figure S2 from CD86+ Antigen-Presenting B Cells Are Increased in Cancer, Localize in Tertiary Lymphoid Structures, and Induce Specific T-cell Responses
18. Table S1 from CD86+ Antigen-Presenting B Cells Are Increased in Cancer, Localize in Tertiary Lymphoid Structures, and Induce Specific T-cell Responses
19. Data from CD86+ Antigen-Presenting B Cells Are Increased in Cancer, Localize in Tertiary Lymphoid Structures, and Induce Specific T-cell Responses
20. Data from Using Antigen-Specific B Cells to Combine Antibody and T Cell–Based Cancer Immunotherapy
21. Supplementary Figures 1-8 from Using Antigen-Specific B Cells to Combine Antibody and T Cell–Based Cancer Immunotherapy
22. Adressen
23. Prognostic accuracy of SOFA, qSOFA and SIRS criteria in hematological cancer patients: a retrospective multicenter study
24. Comparison of bone marrow versus peripheral blood allogeneic hematopoietic stem cell transplantation for hematological malignancies in adults—a systematic review and meta-analysis
25. Characteristics and outcomes of patients undergoing high-dose chemotherapy and autologous stem cell transplantation admitted to the intensive care unit: a single-center retrospective analysis
26. Understanding cytokine release syndrome
27. Reactivation of EBV and CMV in Severe COVID-19—Epiphenomena or Trigger of Hyperinflammation in Need of Treatment? A Large Case Series of Critically ill Patients
28. A multimerized form of recombinant human CD40 ligand supports long-term activation and proliferation of B cells
29. Teamspezifische Auswirkungen der Corona-Pandemie auf Mitarbeiter:innen der Internistischen Intensivmedizin eines Krankenhauses der Maximalversorgung
30. Intensivmedizinische Betreuung hämatologischer und onkologischer Patienten
31. Cytokine release syndrome
32. Anti-thymocyte globulins for post-transplant graft-versus-host disease prophylaxis—A systematic review and meta-analysis
33. Aspergillus tracheobronchitis in COVID-19 patients with acute respiratory distress syndrome: a cohort study
34. CD4+ T cell counts reflect the immunosuppressive state of CD4 helper cells in patients after allogeneic stem cell transplantation
35. Aspergillus tracheobronchitis in COVID-19 ARDS patients – a cohort study
36. Reactivation of EBV and CMV in Severe COVID-19—Epiphenomena or Trigger of Hyperinflammation in Need of Treatment? A Large Case Series of Critically ill Patients
37. Allogeneic stem cell transplant recipients admitted to the intensive care unit during the peri-transplant period have unfavorable outcomes—results of a retrospective analysis from a German university hospital
38. Critical care management of chimeric antigen receptor T‐cell therapy recipients
39. FLAMSA reduced-intensity conditioning is equally effective in AML patients with primary induction failure as well as in first or second complete remission
40. Impact of a half marathon on cellular immune system, pro-inflammatory cytokine levels, and recovery behavior of breast cancer patients in the aftercare compared to healthy controls
41. Chimeric Antigen Receptor T Cells in Myeloma
42. OCTET-CY: a phase II study to investigate the efficacy of post-transplant cyclophosphamide as sole graft-versus-host prophylaxis after allogeneic peripheral blood stem cell transplantation
43. Clinical Course and Outcome of Patients with SARS-CoV-2 Alpha Variant Infection Compared to Patients with SARS-CoV-2 Wild-Type Infection Admitted to the ICU
44. Update 2021: COVID-19 aus Sicht der Intensivmedizin
45. The role of B cells in the pathogenesis of graft-versus-host disease
46. Reactivation of EBV and CMV in Severe COVID-19--Epiphenomena or Trigger of Hyperinflammation in Need of Treatment? A Large Case Series of Critically ill Patients.
47. Feasibility and effectiveness of posaconazole prophylaxis in combination with micafungin bridging for patients undergoing allogeneic stem cell transplantation: A 6-yr analysis from the cologne cohort for neutropenic patients
48. CD86+ Antigen-Presenting B Cells Are Increased in Cancer, Localize in Tertiary Lymphoid Structures, and Induce Specific T-cell Responses
49. Infektionen bei hämatologisch-onkologischen Patienten auf der Intensivstation
50. Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.